HDAC1 inhibition by MS-275 in mesothelial cells limits cellular invasion and promotes MMT reversal

Lucia Rossi, Cecilia Battistelli, Valeria De Turris, Valeria Noce, Clemens Zwergel, Sergio Valente, Alessandra Moioli, Andrea Manzione, Marco Palladino, Veronica Bordoni, Alessandro Domenici, Paolo Menè, Antonello Mai, Marco Tripodi, Raffaele Strippoli

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Peritoneal fibrosis is a pathological alteration of the peritoneal membrane occurring in a variety of conditions including peritoneal dialysis (PD), post-surgery adhesions and peritoneal metastases. The acquisition of invasive and pro-fibrotic abilities by mesothelial cells (MCs) through induction of MMT, a cell-specific form of EMT, plays a main role in this process. Aim of this study was to evaluate possible effects of histone deacetylase (HDAC) inhibitors, key components of the epigenetic machinery, in counteracting MMT observed in MCs isolated from effluent of PD patients. HDAC inhibitors with different class/isoform selectivity have been used for pharmacological inhibition. While the effect of other inhibitors was limited to a partial E-cadherin re-expression, MS-275, a HDAC1-3 inhibitor, promoted: (i) downregulation of mesenchymal markers (MMP2, Col1A1, PAI-1, TGFβ1, TGFβRI) (ii) upregulation of epithelial markers (E-cadherin, Occludin), (iii) reacquisition of an epithelial-like morphology and (iv) marked reduction of cellular invasiveness. Results were confirmed by HDAC1 genetic silencing. Mechanistically, MS-275 causes: (i) increase of nuclear histone H3 acetylation (ii) rescue of the acetylation profile on E-cadherin promoter, (iii) Snail functional impairment. Overall, our study, pinpointing a role for HDAC1, revealed a new player in the regulation of peritoneal fibrosis, providing the rationale for future therapeutic opportunities.

Original languageEnglish
Article number8492
JournalScientific Reports
Volume8
Issue number1
DOIs
Publication statusPublished - Dec 1 2018

Fingerprint

Cadherins
Peritoneal Fibrosis
Histone Deacetylase Inhibitors
Peritoneal Dialysis
Acetylation
Occludin
Plasminogen Activator Inhibitor 1
Epigenomics
Histones
Protein Isoforms
Up-Regulation
Down-Regulation
Pharmacology
Neoplasm Metastasis
Membranes
2-methylcyclopentadienyl manganese tricarbonyl
entinostat
Therapeutics

ASJC Scopus subject areas

  • General

Cite this

Rossi, L., Battistelli, C., De Turris, V., Noce, V., Zwergel, C., Valente, S., ... Strippoli, R. (2018). HDAC1 inhibition by MS-275 in mesothelial cells limits cellular invasion and promotes MMT reversal. Scientific Reports, 8(1), [8492]. https://doi.org/10.1038/s41598-018-26319-2

HDAC1 inhibition by MS-275 in mesothelial cells limits cellular invasion and promotes MMT reversal. / Rossi, Lucia; Battistelli, Cecilia; De Turris, Valeria; Noce, Valeria; Zwergel, Clemens; Valente, Sergio; Moioli, Alessandra; Manzione, Andrea; Palladino, Marco; Bordoni, Veronica; Domenici, Alessandro; Menè, Paolo; Mai, Antonello; Tripodi, Marco; Strippoli, Raffaele.

In: Scientific Reports, Vol. 8, No. 1, 8492, 01.12.2018.

Research output: Contribution to journalArticle

Rossi, L, Battistelli, C, De Turris, V, Noce, V, Zwergel, C, Valente, S, Moioli, A, Manzione, A, Palladino, M, Bordoni, V, Domenici, A, Menè, P, Mai, A, Tripodi, M & Strippoli, R 2018, 'HDAC1 inhibition by MS-275 in mesothelial cells limits cellular invasion and promotes MMT reversal', Scientific Reports, vol. 8, no. 1, 8492. https://doi.org/10.1038/s41598-018-26319-2
Rossi, Lucia ; Battistelli, Cecilia ; De Turris, Valeria ; Noce, Valeria ; Zwergel, Clemens ; Valente, Sergio ; Moioli, Alessandra ; Manzione, Andrea ; Palladino, Marco ; Bordoni, Veronica ; Domenici, Alessandro ; Menè, Paolo ; Mai, Antonello ; Tripodi, Marco ; Strippoli, Raffaele. / HDAC1 inhibition by MS-275 in mesothelial cells limits cellular invasion and promotes MMT reversal. In: Scientific Reports. 2018 ; Vol. 8, No. 1.
@article{741ba21f50e74d3d9b9a21f851c751aa,
title = "HDAC1 inhibition by MS-275 in mesothelial cells limits cellular invasion and promotes MMT reversal",
abstract = "Peritoneal fibrosis is a pathological alteration of the peritoneal membrane occurring in a variety of conditions including peritoneal dialysis (PD), post-surgery adhesions and peritoneal metastases. The acquisition of invasive and pro-fibrotic abilities by mesothelial cells (MCs) through induction of MMT, a cell-specific form of EMT, plays a main role in this process. Aim of this study was to evaluate possible effects of histone deacetylase (HDAC) inhibitors, key components of the epigenetic machinery, in counteracting MMT observed in MCs isolated from effluent of PD patients. HDAC inhibitors with different class/isoform selectivity have been used for pharmacological inhibition. While the effect of other inhibitors was limited to a partial E-cadherin re-expression, MS-275, a HDAC1-3 inhibitor, promoted: (i) downregulation of mesenchymal markers (MMP2, Col1A1, PAI-1, TGFβ1, TGFβRI) (ii) upregulation of epithelial markers (E-cadherin, Occludin), (iii) reacquisition of an epithelial-like morphology and (iv) marked reduction of cellular invasiveness. Results were confirmed by HDAC1 genetic silencing. Mechanistically, MS-275 causes: (i) increase of nuclear histone H3 acetylation (ii) rescue of the acetylation profile on E-cadherin promoter, (iii) Snail functional impairment. Overall, our study, pinpointing a role for HDAC1, revealed a new player in the regulation of peritoneal fibrosis, providing the rationale for future therapeutic opportunities.",
author = "Lucia Rossi and Cecilia Battistelli and {De Turris}, Valeria and Valeria Noce and Clemens Zwergel and Sergio Valente and Alessandra Moioli and Andrea Manzione and Marco Palladino and Veronica Bordoni and Alessandro Domenici and Paolo Men{\`e} and Antonello Mai and Marco Tripodi and Raffaele Strippoli",
year = "2018",
month = "12",
day = "1",
doi = "10.1038/s41598-018-26319-2",
language = "English",
volume = "8",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - HDAC1 inhibition by MS-275 in mesothelial cells limits cellular invasion and promotes MMT reversal

AU - Rossi, Lucia

AU - Battistelli, Cecilia

AU - De Turris, Valeria

AU - Noce, Valeria

AU - Zwergel, Clemens

AU - Valente, Sergio

AU - Moioli, Alessandra

AU - Manzione, Andrea

AU - Palladino, Marco

AU - Bordoni, Veronica

AU - Domenici, Alessandro

AU - Menè, Paolo

AU - Mai, Antonello

AU - Tripodi, Marco

AU - Strippoli, Raffaele

PY - 2018/12/1

Y1 - 2018/12/1

N2 - Peritoneal fibrosis is a pathological alteration of the peritoneal membrane occurring in a variety of conditions including peritoneal dialysis (PD), post-surgery adhesions and peritoneal metastases. The acquisition of invasive and pro-fibrotic abilities by mesothelial cells (MCs) through induction of MMT, a cell-specific form of EMT, plays a main role in this process. Aim of this study was to evaluate possible effects of histone deacetylase (HDAC) inhibitors, key components of the epigenetic machinery, in counteracting MMT observed in MCs isolated from effluent of PD patients. HDAC inhibitors with different class/isoform selectivity have been used for pharmacological inhibition. While the effect of other inhibitors was limited to a partial E-cadherin re-expression, MS-275, a HDAC1-3 inhibitor, promoted: (i) downregulation of mesenchymal markers (MMP2, Col1A1, PAI-1, TGFβ1, TGFβRI) (ii) upregulation of epithelial markers (E-cadherin, Occludin), (iii) reacquisition of an epithelial-like morphology and (iv) marked reduction of cellular invasiveness. Results were confirmed by HDAC1 genetic silencing. Mechanistically, MS-275 causes: (i) increase of nuclear histone H3 acetylation (ii) rescue of the acetylation profile on E-cadherin promoter, (iii) Snail functional impairment. Overall, our study, pinpointing a role for HDAC1, revealed a new player in the regulation of peritoneal fibrosis, providing the rationale for future therapeutic opportunities.

AB - Peritoneal fibrosis is a pathological alteration of the peritoneal membrane occurring in a variety of conditions including peritoneal dialysis (PD), post-surgery adhesions and peritoneal metastases. The acquisition of invasive and pro-fibrotic abilities by mesothelial cells (MCs) through induction of MMT, a cell-specific form of EMT, plays a main role in this process. Aim of this study was to evaluate possible effects of histone deacetylase (HDAC) inhibitors, key components of the epigenetic machinery, in counteracting MMT observed in MCs isolated from effluent of PD patients. HDAC inhibitors with different class/isoform selectivity have been used for pharmacological inhibition. While the effect of other inhibitors was limited to a partial E-cadherin re-expression, MS-275, a HDAC1-3 inhibitor, promoted: (i) downregulation of mesenchymal markers (MMP2, Col1A1, PAI-1, TGFβ1, TGFβRI) (ii) upregulation of epithelial markers (E-cadherin, Occludin), (iii) reacquisition of an epithelial-like morphology and (iv) marked reduction of cellular invasiveness. Results were confirmed by HDAC1 genetic silencing. Mechanistically, MS-275 causes: (i) increase of nuclear histone H3 acetylation (ii) rescue of the acetylation profile on E-cadherin promoter, (iii) Snail functional impairment. Overall, our study, pinpointing a role for HDAC1, revealed a new player in the regulation of peritoneal fibrosis, providing the rationale for future therapeutic opportunities.

UR - http://www.scopus.com/inward/record.url?scp=85048002226&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048002226&partnerID=8YFLogxK

U2 - 10.1038/s41598-018-26319-2

DO - 10.1038/s41598-018-26319-2

M3 - Article

AN - SCOPUS:85048002226

VL - 8

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

IS - 1

M1 - 8492

ER -